Nuveen LLC Trims Stock Holdings in Lam Research Corporation $LRCX

Nuveen LLC decreased its stake in Lam Research Corporation (NASDAQ:LRCX) by 2.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 10,388,923 shares of the semiconductor company’s stock after selling 263,544 shares during the quarter. Lam Research makes up 0.5% of Nuveen LLC’s portfolio, making the stock its 27th biggest holding. Nuveen LLC’s holdings in Lam Research were worth $1,778,376,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also bought and sold shares of the company. PMV Capital Advisers LLC purchased a new stake in Lam Research in the fourth quarter worth about $25,000. Stance Capital LLC purchased a new stake in shares of Lam Research during the third quarter worth about $26,000. Triumph Capital Management purchased a new stake in shares of Lam Research during the third quarter worth about $27,000. Core Wealth Advisors LLC purchased a new stake in shares of Lam Research during the fourth quarter worth about $29,000. Finally, Strategic Wealth Investment Group LLC purchased a new stake in shares of Lam Research during the second quarter worth about $29,000. Hedge funds and other institutional investors own 84.61% of the company’s stock.

Lam Research Price Performance

NASDAQ:LRCX opened at $362.52 on Friday. The firm has a market capitalization of $453.36 billion, a price-to-earnings ratio of 68.40, a PEG ratio of 2.66 and a beta of 1.85. Lam Research Corporation has a 1 year low of $87.75 and a 1 year high of $364.81. The business has a 50 day simple moving average of $283.21 and a 200-day simple moving average of $232.64. The company has a debt-to-equity ratio of 0.35, a current ratio of 2.54 and a quick ratio of 1.77.

Lam Research (NASDAQ:LRCX) last issued its quarterly earnings results on Wednesday, April 22nd. The semiconductor company reported $1.47 earnings per share for the quarter, topping the consensus estimate of $1.36 by $0.11. Lam Research had a return on equity of 66.21% and a net margin of 30.94%.The firm had revenue of $5.84 billion for the quarter, compared to the consensus estimate of $5.70 billion. During the same period in the prior year, the business posted $1.04 earnings per share. The company’s revenue for the quarter was up 23.8% on a year-over-year basis. Lam Research has set its Q4 2026 guidance at 1.500-1.800 EPS. Equities analysts forecast that Lam Research Corporation will post 5.67 EPS for the current year.

Lam Research Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, July 8th. Stockholders of record on Wednesday, June 17th will be issued a $0.26 dividend. The ex-dividend date is Wednesday, June 17th. This represents a $1.04 dividend on an annualized basis and a dividend yield of 0.3%. Lam Research’s dividend payout ratio (DPR) is currently 19.62%.

Insiders Place Their Bets

In other Lam Research news, insider Ava Harter sold 6,010 shares of Lam Research stock in a transaction dated Monday, April 27th. The stock was sold at an average price of $258.66, for a total transaction of $1,554,546.60. Following the completion of the sale, the insider owned 53,205 shares of the company’s stock, valued at approximately $13,762,005.30. The trade was a 10.15% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, SVP Neil J. Fernandes sold 18,170 shares of Lam Research stock in a transaction dated Friday, May 1st. The stock was sold at an average price of $255.14, for a total value of $4,635,893.80. Following the sale, the senior vice president directly owned 66,129 shares of the company’s stock, valued at approximately $16,872,153.06. This represents a 21.55% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 31,839 shares of company stock worth $8,561,667 over the last quarter. Company insiders own 0.31% of the company’s stock.

More Lam Research News

Here are the key news stories impacting Lam Research this week:

• Positive Sentiment: Barclays and other analysts raised price targets on Lam Research after increasing their wafer-fab equipment spending estimates, reinforcing the view that AI infrastructure investment is still running strong and could support more orders for chipmaking tools. Barclays raises price targets on chip stocks after raising WFE estimates
• Positive Sentiment: Lam’s CFO recently lifted the company’s 2026 wafer-fab equipment market forecast to $140 billion, which suggests a stronger spending backdrop for its core business and improved momentum into the second half of the year. Lam Research jumps as upbeat chip-equipment spending outlook and fresh analyst target hikes lift sentiment
• Positive Sentiment: The company’s latest quarterly results beat expectations, with revenue and EPS both ahead of consensus, and guidance pointed to further sequential growth, helping investors believe the business is still in an upcycle. Lam Research jumps as upbeat chip-equipment spending outlook and fresh analyst target hikes lift sentiment
• Neutral Sentiment: Several articles also highlighted Lam Research as a beneficiary of the broader AI infrastructure boom and a “critical enabler” of AI growth, which keeps sentiment constructive, though these pieces were more thematic than company-specific. Lam Research: A Critical Enabler Of AI Growth, Reiterating Buy
• Negative Sentiment: Near-term trading has been volatile, and one recent report noted the stock fell in the prior session, showing that some investors are still worried about valuation and the possibility of a cyclical slowdown after a strong run. Lam Research (LRCX) Falls More Steeply Than Broader Market: What Investors Need to Know

Analyst Upgrades and Downgrades

Several analysts recently issued reports on LRCX shares. Weiss Ratings cut Lam Research from a “buy (b)” rating to a “buy (b-)” rating in a research report on Thursday, May 14th. Royal Bank Of Canada increased their target price on Lam Research from $290.00 to $310.00 and gave the stock an “outperform” rating in a research report on Thursday, April 23rd. UBS Group reiterated a “buy” rating and set a $375.00 target price (up from $310.00) on shares of Lam Research in a research report on Tuesday. Barclays reiterated an “overweight” rating and set a $335.00 target price on shares of Lam Research in a research report on Thursday. Finally, Sanford C. Bernstein increased their target price on Lam Research from $325.00 to $340.00 and gave the stock an “outperform” rating in a research report on Thursday, May 21st. Twenty-eight investment analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $322.01.

About Lam Research

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.